Endurant Capital Management as of Dec. 31, 2022
Portfolio Holdings for Endurant Capital Management
Endurant Capital Management holds 55 positions in its portfolio as reported in the December 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Invacare Corp Note 5.000%11/1 | 19.8 | $49M | 57M | 0.86 | |
| Laboratory Corp Amer Hldgs Com New (LH) | 8.7 | $21M | 91k | 235.48 | |
| Cigna Corp (CI) | 6.7 | $17M | 50k | 331.34 | |
| Merck & Co (MRK) | 5.7 | $14M | 126k | 110.95 | |
| Centene Corporation (CNC) | 5.6 | $14M | 168k | 82.01 | |
| Anthem (ELV) | 5.4 | $13M | 26k | 512.97 | |
| Icon SHS (ICLR) | 4.6 | $11M | 59k | 194.25 | |
| Astrazeneca Sponsored Adr (AZN) | 3.9 | $9.6M | 141k | 67.80 | |
| BioMarin Pharmaceutical (BMRN) | 3.5 | $8.7M | 84k | 103.49 | |
| Invacare Corp Note 5.000%11/1 | 3.4 | $8.5M | 10M | 0.84 | |
| Sabra Health Care REIT (SBRA) | 2.2 | $5.4M | 437k | 12.43 | |
| Aziyo Biologics Cl A Com (ELUT) | 2.2 | $5.4M | 1.3M | 4.25 | |
| Insmed Com Par $.01 (INSM) | 2.0 | $4.9M | 243k | 19.98 | |
| Albireo Pharma | 1.9 | $4.7M | 217k | 21.61 | |
| Encompass Health Corp (EHC) | 1.9 | $4.7M | 78k | 59.81 | |
| Selecta Biosciences (RNAC) | 1.7 | $4.3M | 3.8M | 1.13 | |
| Viking Therapeutics (VKTX) | 1.7 | $4.1M | 433k | 9.40 | |
| AmerisourceBergen (COR) | 1.4 | $3.5M | 21k | 165.71 | |
| Biontech Se Sponsored Ads (BNTX) | 1.3 | $3.3M | 22k | 150.22 | |
| Ocular Therapeutix (OCUL) | 1.2 | $3.0M | 1.1M | 2.81 | |
| Adaptimmune Therapeutics Sponds Adr (ADAP) | 1.0 | $2.5M | 1.7M | 1.46 | |
| Zoetis Cl A (ZTS) | 1.0 | $2.5M | 17k | 146.55 | |
| Sutro Biopharma (STRO) | 0.9 | $2.3M | 282k | 8.08 | |
| Qiagen Nv Shs New | 0.8 | $2.0M | 41k | 49.87 | |
| Tenet Healthcare Corp Com New (THC) | 0.8 | $2.0M | 41k | 48.79 | |
| Becton, Dickinson and (BDX) | 0.7 | $1.7M | 6.8k | 254.30 | |
| Bio Rad Labs Cl A (BIO) | 0.7 | $1.6M | 3.9k | 420.49 | |
| Catalent (CTLT) | 0.6 | $1.6M | 35k | 45.01 | |
| Silk Road Medical Inc Common (SILK) | 0.6 | $1.6M | 30k | 52.85 | |
| Hca Holdings (HCA) | 0.6 | $1.6M | 6.6k | 239.96 | |
| Peak (DOC) | 0.6 | $1.5M | 60k | 25.07 | |
| Terns Pharmaceuticals (TERN) | 0.6 | $1.4M | 136k | 10.18 | |
| Charles River Laboratories (CRL) | 0.6 | $1.4M | 6.3k | 217.90 | |
| Arrowhead Pharmaceuticals (ARWR) | 0.5 | $1.1M | 28k | 40.56 | |
| Bioatla (BCAB) | 0.5 | $1.1M | 136k | 8.25 | |
| 10x Genomics Cl A Com (TXG) | 0.4 | $1.1M | 30k | 36.44 | |
| Alnylam Pharmaceuticals (ALNY) | 0.4 | $1.1M | 4.6k | 237.65 | |
| Gritstone Oncology Ord (GRTS) | 0.4 | $976k | 283k | 3.45 | |
| Thermo Fisher Scientific (TMO) | 0.4 | $875k | 1.6k | 550.69 | |
| Axsome Therapeutics (AXSM) | 0.4 | $869k | 11k | 77.13 | |
| Dentsply Sirona (XRAY) | 0.3 | $703k | 22k | 31.84 | |
| Ptc Therapeutics I (PTCT) | 0.3 | $683k | 18k | 38.17 | |
| Intellia Therapeutics (NTLA) | 0.2 | $572k | 16k | 34.89 | |
| Baxter International (BAX) | 0.2 | $561k | 11k | 50.97 | |
| Igm Biosciences (IGMS) | 0.2 | $516k | 30k | 17.01 | |
| Actinium Pharmaceuticals (ATNM) | 0.2 | $486k | 46k | 10.65 | |
| 89bio (ETNB) | 0.2 | $468k | 37k | 12.73 | |
| Iovance Biotherapeutics (IOVA) | 0.2 | $452k | 71k | 6.39 | |
| Iteos Therapeutics (ITOS) | 0.2 | $411k | 21k | 19.53 | |
| Inhibrx (INBX) | 0.1 | $332k | 14k | 24.64 | |
| Maravai Lifesciences Hldgs I Com Cl A (MRVI) | 0.1 | $307k | 22k | 14.31 | |
| Biodesix (BDSX) | 0.1 | $286k | 124k | 2.30 | |
| Biomea Fusion (BMEA) | 0.1 | $286k | 34k | 8.43 | |
| Oyster Point Pharma | 0.1 | $223k | 20k | 11.17 | |
| Athenex | 0.1 | $133k | 902k | 0.15 |
